Work

Donanemab (Kisunla) for Alzheimer's Disease

Year: 2024

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2024.1709a

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401595812

FWCI: 0.957

Cites:

Cited by: 4

Related to: 10